Live Bending Spoons Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Amneal Pharmaceuticals, Inc.

AMRX

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in developing, manufacturing, marketing, and distributing a broad portfolio of essential medicines. Its business segments include Affordable Medicines (generics, injectables, biosimilars), Specialty branded pharmaceuticals focused on central nervous system and endocrine disorders, and AvKARE, a pharmaceutical distributor serving U.S. government and institutional markets. Amneal leverages complex formulations, vertical integration, and regulatory expertise to deliver cost-effective, high-value pharmaceutical products primarily in the U.S., India, and Ireland.

This description was generated via AI from an annual report. Updated about 1 year ago.

Latest SEC Filings from Amneal Pharmaceuticals, Inc.